CD200 and myelodysplastic syndrome: Our results are in agreement with previous ones that reported that not only MDS patients display over-expression of CD200 on CD33+ bone marrow cells, but also CD200 expression was significantly associated with high risk MDS subtype being higher in high risk group as compared to intermediate risk group.